Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: A community practice experience

被引：6
|
作者：
Shen, Huafeng [1 ]
Lipka, Seth [2 ]
Katz, Seymour [3 ,4 ,5 ]
机构：
[1] Nassau Univ, Med Ctr, Dept Med, E Meadow, NY USA
[2] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33612 USA
[3] NYU, Sch Med, New York, NY USA
[4] North Shore Univ Hosp Ong Isl Jewish Hlth Syst, Manhasset, NY USA
[5] St Francis Hosp, Roslyn, NY USA
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷 / 08期
关键词：
D O I：
10.1016/j.crohns.2013.12.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：898 / 899
页数：2
相关论文
共 50 条
  • [41] Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease
    Dolovich, Casandra
    Bernstein, Charles N.
    Singh, Harminder
    Nugent, Zoann
    Tennakoon, Aruni
    Shafer, Leigh Ann
    Marrie, Ruth Ann
    Sareen, Jitender
    Targownik, Laura E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (06) : 1200 - +
  • [42] Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
    Riestra, Sabin
    de Francisco, Ruth
    Arias-Guillen, Miguel
    Saro, Cristina
    Garcia-Alvarado, Maria
    Duque, Jose M.
    Jose Palacios, Juan
    Munoz, Fernando
    Blanco, Lorena
    Castano, Olegario
    Perez-Martinez, Isabel
    Martinez-Camblor, Pablo
    Perez-Hernandez, Dolores
    Suarez, Adolfo
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (09) : 541 - 549
  • [43] Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
    Park, Jihye
    Cheon, Jae Hee
    GUT AND LIVER, 2021, 15 (05) : 641 - 642
  • [44] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Lew, Daniel
    Yoon, Soon Man
    Yan, Xiaofei
    Robbins, Lori
    Haritunians, Talin
    Liu, Zhenqiu
    Li, Dalin
    McGovern, Dermot P. B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (40) : 7265 - 7273
  • [45] REAL-WORLD TREATMENT PATTERNS WITH ANTI-TUMOR NECROSIS FACTOR THERAPY IN INFLAMMATORY BOWEL DISEASE IN ISRAEL
    Weil, C.
    Chodick, G.
    Yarden, A.
    Khalid, J. M.
    Shalev, V
    VALUE IN HEALTH, 2016, 19 (07) : A509 - A510
  • [46] Is It Prime Time for Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease?
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    GASTROENTEROLOGY, 2019, 157 (04) : 922 - 924
  • [47] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Daniel Lew
    Soon Man Yoon
    Xiaofei Yan
    Lori Robbins
    Talin Haritunians
    Zhenqiu Liu
    Dalin Li
    Dermot PB McGovern
    World Journal of Gastroenterology, 2017, (40) : 7265 - 7273
  • [48] Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
    Kim, Jihye
    Im, Jong Pil
    Yim, Jae-Joon
    Lee, Chang Kyun
    Park, Dong Il
    Eun, Chang Soo
    Jung, Sung-Ae
    Shin, Jeong Eun
    Lee, Kang-Moon
    Cheon, Jae Hee
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (01): : 29 - +
  • [49] Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Marsal, Jan
    Barreiro-de Acosta, Manuel
    Blumenstein, Irina
    Cappello, Maria
    Bazin, Thomas
    Sebastian, Shaji
    FRONTIERS IN MEDICINE, 2022, 9
  • [50] Vitamin D status and response to anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease
    Bak, N. F.
    Hald, S.
    Rasch, M. B.
    Dige, A.
    Agnholt, J. S.
    Dahlerup, J. F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S318 - S318
12345